ArticleJournal of cancer survivorship : research and practice2026
Effects of the Fit2Thrive technology-supported physical activity promotion intervention components on sedentary behavior and light physical activity in breast cancer survivors.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
purposeLess sedentary time (ST) and more light physical activity (LPA) are associated with improved health outcomes among breast cancer survivors. However, less is known about whether interventions designed to increase moderate-to-vigorous physical activity (MVPA) also influence time spent sedentary and in LPA. This study explored the overall and component-specific effects of the Fit2Thrive technology-supported MVPA intervention on ST and LPA in breast cancer survivors.
methodsPhysically inactive breast cancer survivors (n = 269; M
resultsCompared to baseline, ST significantly decreased at 12 weeks (β = -14.2 min/day; p < 0.01); reductions were maintained at 24 weeks (β = -11.0 min/day; p < 0.01). LPA significantly increased at 24 weeks (β = 7.4 min/day; p = 0.04), but not at 12 weeks. No component effects were significant. Greater increases in MVPA were associated with greater ST decreases and LPA increases. Time since diagnosis moderated effects of the Deluxe App on ST and LPA.
conclusionsParticipation in an mHealth MVPA promotion trial was associated with modest reductions in ST and increases in LPA, while also increasing MVPA. Findings suggest the core intervention may have been sufficient to support favorable changes across movement behaviors. Future research should investigate how to enhance effects while maximizing MVPA and health outcomes. IMPLICATIONS FOR CANCER SURVIVORS: Participation in an mHealth MVPA promotion trial may also result in reduced ST and increased LPA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.